Nachrichten zur PTC Therapeutics Aktie

PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -19.90% and 6.59%, respectively, for the quarter ended December 2022. Do…

Form 10-K PTC THERAPEUTICS, INC. For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K PTC THERAPEUTICS, INC. For: Feb 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earnings Outlook For PTC Therapeutics

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results

SOUTH PLAINFIELD, N.J., Feb. 7, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host…

PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation

- This award recognizes PTCs 25-year legacy in discovering and delivering novel therapies that address the underlying cause of rare…

Insiderhandel: CHIEF TECHNICAL OPS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 30.024$

Almstead, Neil Gregory - Vorstand - Tag der Transaktion: 2023-01-31...…

Insiderhandel: CHIEF EXECUTIVE OFFICER verkauft Aktien von PTC Therapeutics im Wert von 119.591$

Peltz, Stuart Walter - Vorstand - Tag der Transaktion: 2023-01-31...…

Insiderhandel: SVP, FINANCE & CAO verkauft Aktien von PTC Therapeutics im Wert von 14.829$

Utter, Christine Marie - Vorstand - Tag der Transaktion: 2023-01-31...…

PTC Therapeutics to Participate at Upcoming Investor Conference

SOUTH PLAINFIELD, N.J., Feb. 2, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present…

Insiderhandel: CHIEF FINANCIAL OFFICER verkauft Aktien von PTC Therapeutics im Wert von 31.575$

Hill, Emily Luisa - Vorstand - Tag der Transaktion: 2023-01-09...…

Insiderhandel: CHIEF TECHNICAL OPS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 31.617$

Almstead, Neil Gregory - Vorstand - Tag der Transaktion: 2023-01-09...…

Insiderhandel: CHIEF OPERATING OFFICER verkauft Aktien von PTC Therapeutics im Wert von 30.451$

Klein, Matthew B. - Vorstand - Tag der Transaktion: 2023-01-09...…

Insiderhandel: SVP, FINANCE & CAO verkauft Aktien von PTC Therapeutics im Wert von 29.409$

Utter, Christine Marie - Vorstand - Tag der Transaktion: 2023-01-09...…

Insiderhandel: CHIEF BUSINESS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 35.741$

Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-01-09...…

Insiderhandel: EXEC. VP AND CLO verkauft Aktien von PTC Therapeutics im Wert von 34.783$

Boulding, Mark Elliott - Vorstand - Tag der Transaktion: 2023-01-09...…

Insiderhandel: CHIEF EXECUTIVE OFFICER verkauft Aktien von PTC Therapeutics im Wert von 86.020$

Peltz, Stuart Walter - Vorstand - Tag der Transaktion: 2023-01-09...…

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH PLAINFIELD, N.J., Jan. 11, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 5, 2023,…

PTC Therapeutics (PTCT) Soars 5.8%: Is Further Upside Left in the Stock?

PTC Therapeutics (PTCT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions…

PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference

- ~$710 million unaudited 2022 total revenue, representing an impressive over 30% year-over-year growth – - $940 million - $1.0…

Form 8-K PTC THERAPEUTICS, INC. For: Jan 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Kaskela Law LLC Announces Investigation of PTC Therapeutics, Inc. (PTCT) and Encourages Long-Term PTCT Investors to Contact the Firm

Philadelphia, Pennsylvania--(Newsfile Corp. - January 6, 2023) - Kaskela Law LLC announces that it is investigating PTC Therapeutics, Inc. (NASDAQ:…

PTC Therapeutics to Participate at 41st Annual J.P. Morgan Healthcare Conference

SOUTH PLAINFIELD, N.J., Jan. 4, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present…

Form 8-K PTC THERAPEUTICS, INC. For: Dec 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moore Kuehn, PLLC Encourages Investors of PTC Therapeutics, Inc. to Contact Law Firm

New York, New York--(Newsfile Corp. - December 5, 2022) - Moore Kuehn, PLLC, a securities law firm located on Wall…

PTC Therapeutics gets Brazilian nod for treatment of a rare condition of body fat

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

PTC Therapeutics gene therapy Upstaza for rare neuromuscular disorder gets approval in UK

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc.…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

New York, New York--(Newsfile Corp. - November 9, 2022) - Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc.…

PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -11.68% and 11.82%, respectively, for the quarter ended September 2022. Do…

Form 10-Q PTC THERAPEUTICS, INC. For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K PTC THERAPEUTICS, INC. For: Oct 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Insiderhandel: EXEC. VP AND CLO verkauft Aktien von PTC Therapeutics im Wert von 16.462$

Boulding, Mark Elliott - Vorstand - Tag der Transaktion: 2022-10-18...…

Insiderhandel: EXEC. VP AND CLO verkauft Aktien von PTC Therapeutics im Wert von 363.110$

Boulding, Mark Elliott - Vorstand - Tag der Transaktion: 2022-10-17...…

Reaction Is Overdone For PTC Therapeutics Pausing Huntington Trial Enrollment, Analyst Says

Latest Ratings for PTCT DateFirmActionFromTo Feb 2022JP MorganMaintainsOverweight Feb 2022BarclaysMaintainsEqual-Weight Oct 2021Raymond JamesMaintainsOutperform View More…

PTC Therapeutics shares fall 10% after announcing pause in U.S. enrollment for a clinical trial

Shares of PTC Therapeutics Inc. were down 10.1% in trading on Wednesday morning, the day after the company said…

PTC Therapeutics Shares Fall Premarket on U.S. Study Pause >PTCT

PTC Therapeutics Shares Fall Premarket on U.S. Study Pause >PTCT...…

Form 8-K PTC THERAPEUTICS, INC. For: Oct 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

PTC Therapeutics falls as partner Roche reports Q3 sales for SMA therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2022 Financial Results

SOUTH PLAINFIELD, N.J., Oct. 13, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host…

dpa-AFX ProFeed